Avalo Therapeutics
AVTX
AVTX
18 hedge funds and large institutions have $1.9M invested in Avalo Therapeutics in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.01M | |
| 2 | +$221K | |
| 3 | +$218K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$168K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$131K |
Top Sellers
| 1 | -$299K | |
| 2 | -$45.5K | |
| 3 | -$4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.74K |
| 5 |
Morgan Stanley
New York
|
-$1.06K |